tiprankstipranks
Gyre Therapeutics (GYRE)
NASDAQ:GYRE

Gyre Therapeutics (GYRE) Balance Sheet

797 Followers

Gyre Therapeutics Balance Sheet

Gyre Therapeutics's total assets for Q1 2024 were $122.01M, an increase of 1124.51% from the previous quarter. GYRE total liabilities were $33.24M for the fiscal quarter, a 415.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 110.53M$ 28.44M$ 55.66M$ 94.85M$ 98.55M
Total Liabilities
$ 102.59M$ 50.13M$ 14.57M$ 18.78M$ 30.22M
Total Equity Gross Minority
$ 13.95M$ -21.69M$ 41.09M$ 76.07M$ 68.34M
Total Capitalization
$ -15.63M$ -21.69M$ 41.09M$ 76.07M$ 68.34M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 1.64M$ 1.80M
Currency in USD

Gyre Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis